HomeAUPH • NASDAQ
add
Aurinia Pharmaceuticals Inc
Previous close
$11.70
Day range
$11.36 - $11.79
Year range
$5.25 - $11.80
Market cap
1.53B USD
Avg Volume
2.51M
P/E ratio
27.16
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 70.01M | 22.41% |
Operating expense | 35.26M | -21.01% |
Net income | 21.51M | 2,879.64% |
Net profit margin | 30.73 | 2,338.89% |
Earnings per share | 0.16 | 1,500.00% |
EBITDA | 25.06M | 469.31% |
Effective tax rate | 2.90% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 315.04M | -4.63% |
Total assets | 502.56M | -4.00% |
Total liabilities | 167.26M | 5.25% |
Total equity | 335.30M | — |
Shares outstanding | 131.63M | — |
Price to book | 4.62 | — |
Return on assets | 10.02% | — |
Return on capital | 11.95% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 21.51M | 2,879.64% |
Cash from operations | 44.24M | 179.25% |
Cash from investing | -13.27M | 65.63% |
Cash from financing | -44.39M | -436.61% |
Net change in cash | -13.43M | 56.76% |
Free cash flow | 29.57M | 69.37% |
About
Founded
2012
Headquarters
Website
Employees
130
